ALYSSIA BURGESS: Open Payments
NPI 1184269953 · LAWRENCEBURG, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,320 in 65 payments from 10 companies in 2025. Trend: 2023 $784 · 2024 $938 · 2025 $1,320
Food & beverage: $1,320
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 17 | $392 |
| E.R. Squibb & Sons, L.L.C. | 10 | $225 |
| Otsuka America Pharmaceutical, Inc. | 11 | $207 |
| ABBVIE INC. | 12 | $139 |
| Janssen Pharmaceuticals, Inc | 5 | $103 |
| Lundbeck LLC | 4 | $96 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
Products named: ARISTADA, COBENFY, REXULTI, VRAYLAR, INVEGA SUSTENNA, ABILIFY MAINTENA, Auvelity, INGREZZA.
Industry payments across TN — which companies pay providers there.
